Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$446,029,479
+$52,963,115 QoQ
Shares Held
1,756,229
+9.2% QoQ
Ownership
0.073%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#113
of 4,664 holders
Holding Since
Sep 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Quantinno Capital Management LP holds $2,173,508,170 across 16 Drug Manufacturers - General names. JNJ ranks #2 (20.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
547,546 | $656,743,153 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
1,756,229 | $446,029,479 | |
| 3 | ABBV |
AbbVie Inc.
|
1,138,736 | $286,551,527 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,523,212 | $195,732,742 | |
| 5 | AMGN |
Amgen Inc
|
425,632 | $154,129,859 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
722,993 | $91,342,935 | |
| 7 | PFE |
Pfizer Inc
|
2,712,410 | $65,314,832 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,121,564 | $64,624,517 |
All Filings in JNJ
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $446,029,479 | 1,756,229 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $393,066,364 | 1,608,028 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $259,674,444 | 1,254,769 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $190,500,322 | 1,027,399 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $95,374,045 | 624,380 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $79,373,843 | 478,617 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $43,460,768 | 300,517 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $35,588,213 | 219,599 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $24,889,878 | 170,292 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $25,329,224 | 160,119 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $15,968,357 | 101,878 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $16,123,084 | 103,519 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $10,955,934 | 66,191 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $6,357,325 | 41,015 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $13,684,722 | 77,468 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $8,530,495 | 52,219 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $7,611,451 | 42,879 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,038,226 | 34,070 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $5,249,111 | 30,684 | Shares | Sole | 2022-02-14 | |
| 2020-09-30 | $619,340 | 4,160 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||